Literature DB >> 16647042

Curcumin potently blocks Kv1.4 potassium channels.

Haiyan Liu1, Sanjay J Danthi, John J Enyeart.   

Abstract

Curcumin, a major constituent of the spice turmeric, is a nutriceutical compound reported to possess therapeutic properties against a variety of diseases ranging from cancer to cystic fibrosis. In whole-cell patch-clamp experiments on bovine adrenal zona fasciculata (AZF) cells, curcumin reversibly inhibited the Kv1.4K+ current with an IC50 of 4.4 microM and a Hill coefficient of 2.32. Inhibition by curcumin was significantly enhanced by repeated depolarization; however, this agent did not alter the voltage-dependence of steady-state inactivation. Kv1.4 is the first voltage-gated ion channel demonstrated to be inhibited by curcumin. Furthermore, these results identify curcumin as one of the most potent antagonists of these K+ channels identified thus far. It remains to be seen whether any of the therapeutic actions of curcumin might originate with its ability to inhibit Kv1.4 or other voltage-gated K+ channel.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16647042      PMCID: PMC2656109          DOI: 10.1016/j.bbrc.2006.04.020

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  34 in total

Review 1.  Multiple biological activities of curcumin: a short review.

Authors:  Radha K Maheshwari; Anoop K Singh; Jaya Gaddipati; Rikhab C Srimal
Journal:  Life Sci       Date:  2006-01-18       Impact factor: 5.037

2.  Presynaptic localization of Kv1.4-containing A-type potassium channels near excitatory synapses in the hippocampus.

Authors:  E C Cooper; A Milroy; Y N Jan; L Y Jan; D H Lowenstein
Journal:  J Neurosci       Date:  1998-02-01       Impact factor: 6.167

3.  Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo.

Authors:  Fusheng Yang; Giselle P Lim; Aynun N Begum; Oliver J Ubeda; Mychica R Simmons; Surendra S Ambegaokar; Pingping P Chen; Rakez Kayed; Charles G Glabe; Sally A Frautschy; Gregory M Cole
Journal:  J Biol Chem       Date:  2004-12-07       Impact factor: 5.157

4.  Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions.

Authors:  A L Cheng; C H Hsu; J K Lin; M M Hsu; Y F Ho; T S Shen; J Y Ko; J T Lin; B R Lin; W Ming-Shiang; H S Yu; S H Jee; G S Chen; T M Chen; C A Chen; M K Lai; Y S Pu; M H Pan; Y J Wang; C C Tsai; C Y Hsieh
Journal:  Anticancer Res       Date:  2001 Jul-Aug       Impact factor: 2.480

5.  Curcumin selectively induces apoptosis in deregulated cyclin D1-expressed cells at G2 phase of cell cycle in a p53-dependent manner.

Authors:  Tathagata Choudhuri; Suman Pal; Tanya Das; Gaurisankar Sa
Journal:  J Biol Chem       Date:  2005-02-28       Impact factor: 5.157

6.  A bovine adrenocortical Kv1.4 K(+) channel whose expression is potently inhibited by ACTH.

Authors:  J A Enyeart; L Xu; J J Enyeart
Journal:  J Biol Chem       Date:  2000-11-03       Impact factor: 5.157

7.  Curcumin stimulates cystic fibrosis transmembrane conductance regulator Cl- channel activity.

Authors:  Allan L Berger; Christoph O Randak; Lynda S Ostedgaard; Philip H Karp; Daniel W Vermeer; Michael J Welsh
Journal:  J Biol Chem       Date:  2004-12-06       Impact factor: 5.157

8.  Differential effects of S6 mutations on binding of quinidine and 4-aminopyridine to rat isoform of Kv1.4: common site but different factors in determining blockers' binding affinity.

Authors:  H Zhang; B Zhu; J A Yao; G N Tseng
Journal:  J Pharmacol Exp Ther       Date:  1998-10       Impact factor: 4.030

9.  Adrenocorticotropic hormone and cAMP inhibit noninactivating K+ current in adrenocortical cells by an A-kinase-independent mechanism requiring ATP hydrolysis.

Authors:  J J Enyeart; B Mlinar; J A Enyeart
Journal:  J Gen Physiol       Date:  1996-10       Impact factor: 4.086

10.  Distinct transient outward potassium current (Ito) phenotypes and distribution of fast-inactivating potassium channel alpha subunits in ferret left ventricular myocytes.

Authors:  M V Brahmajothi; D L Campbell; R L Rasmusson; M J Morales; J S Trimmer; J M Nerbonne; H C Strauss
Journal:  J Gen Physiol       Date:  1999-04       Impact factor: 4.086

View more
  6 in total

1.  Curcumin inhibits bTREK-1 K+ channels and stimulates cortisol secretion from adrenocortical cells.

Authors:  Judith A Enyeart; Haiyan Liu; John J Enyeart
Journal:  Biochem Biophys Res Commun       Date:  2008-04-10       Impact factor: 3.575

2.  Curcumin inhibits ACTH- and angiotensin II-stimulated cortisol secretion and Ca(v)3.2 current.

Authors:  Judith A Enyeart; Haiyan Liu; John J Enyeart
Journal:  J Nat Prod       Date:  2009-08       Impact factor: 4.050

3.  Curcumin Acts as a Positive Allosteric Modulator of α7-Nicotinic Acetylcholine Receptors and Reverses Nociception in Mouse Models of Inflammatory Pain.

Authors:  Eslam Gaber El Nebrisi; Deniz Bagdas; Wisam Toma; Halima Al Samri; Anna Brodzik; Yasmin Alkhlaif; Keun-Hang Susan Yang; Frank Christopher Howarth; Imad M Damaj; Murat Oz
Journal:  J Pharmacol Exp Ther       Date:  2018-01-16       Impact factor: 4.030

4.  Curcumin affects cell survival and cell volume regulation in human renal and intestinal cells.

Authors:  Sonja Kössler; Charity Nofziger; Martin Jakab; Silvia Dossena; Markus Paulmichl
Journal:  Toxicology       Date:  2011-12-09       Impact factor: 4.221

Review 5.  Potassium channels in articular chondrocytes.

Authors:  Ali Mobasheri; Rebecca Lewis; Alexandrina Ferreira-Mendes; Ana Rufino; Caroline Dart; Richard Barrett-Jolley
Journal:  Channels (Austin)       Date:  2012-10-12       Impact factor: 2.581

6.  Curcumin inhibits activation of TRPM2 channels in rat hepatocytes.

Authors:  E Kheradpezhouh; G J Barritt; G Y Rychkov
Journal:  Redox Biol       Date:  2015-11-10       Impact factor: 11.799

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.